05/15/2025
6:33 PM | ADAR1 Capital Management, LLC (Filed by)
Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/08/2025
6:51 AM | Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SCHEDULE 13G/A | |
04/16/2025
7:58 PM | D'Andrea Carrie (Reporting)
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
7:58 PM | Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Kohli Prashant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
7:58 PM | DelAversano Robert J (Reporting)
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
7:58 PM | Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Macdonald R. Loch (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
7:58 PM | Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Kumar Amresh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
7:00 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2025
11:15 PM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form EFFECT | |
03/10/2025
6:58 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/03/2025
7:00 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for GRCE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/25/2025
2:05 PM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/18/2025
7:25 PM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 10-Q/A | |
02/13/2025
7:00 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
6:30 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/10/2025
7:11 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
5:13 AM | Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SCHEDULE 13G/A | |
11/14/2024
10:58 AM | BANK OF AMERICA CORP /DE/ (Filed by)
Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
7:00 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
6:30 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024
7:22 AM | Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
7:13 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
11:15 PM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form EFFECT | |
10/15/2024
11:15 PM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form EFFECT | |
10/08/2024
6:22 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/08/2024
6:13 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form POS AM | |
10/08/2024
6:15 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form POS AM | |
10/08/2024
6:16 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-8 POS | |
10/08/2024
6:16 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-8 POS | |
10/08/2024
6:16 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-8 POS | |
09/30/2024
3:31 PM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
7:00 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
7:00 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:30 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
3:14 PM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 424B3 | |
08/04/2024
11:15 PM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form EFFECT | |
07/31/2024
6:22 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-4/A | |
07/11/2024
10:16 AM | Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
| Form 3/A | |
07/10/2024
8:10 PM | Acasti Pharma Inc. (Subject)
Grace Therapeutics (Subject)
ADAR1 Capital Management, LLC (Filed by)
| Form SC 13G | |
07/09/2024
7:29 PM | Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/27/2024
4:01 PM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
Elon’s BIGGEST warning yet? (Ad) Tesla's About to Prove Everyone Wrong... Again
Back in 2018, when Jeff Brown told everyone to buy Tesla…
The "experts" said Elon was finished and Tesla was headed for bankruptcy.
Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. |
06/21/2024
7:00 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
6:30 AM | Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Buy GRCE Stock Free GRCE Stock Alerts